Assessment of risk factors for Neonatal Abstinence Syndrome (NAS) using a Standardized Surveillance Case Definition in Clark County, NV
DOI:
https://doi.org/10.26911/thejmch.2024.09.01.07Abstract
Background: Neonatal Abstinence Syndrome (NAS) is a withdrawal syndrome in neonates that can occur due to drug exposure during pregnancy. This study had two objectives: (1) Assess the implementation of the Council of State and Territorial Epidemiologists (CSTE) Tier 2 case definition for NAS surveillance in Clark County, Nevada and (2) Identify risk factors for NAS.
Subjects and Method: This study utilized hospital discharge data. Claim-based records from non-federal acute care hospitals located in Clark County during 2016-2022 were analyzed. All newborn inpatient discharge records from January 1, 2016 to September 30, 2022 in Clark County, Nevada were selected. ICD-10-CM codes were utilized based on the CSTE Tier 2 case definition. Any neonate record that met the case definition, including any record with the diagnosis code P96.1, was considered a NAS confirmed case. Codes for suspect cases, maternal history of substance use, unspecified maternal medication, and transmitted noxious-substances were also assessed. A multiple logistic regression model using backward stepwise selection was developed to find risk factors related to NAS-confirmed births.
Results: In Clark County, Nevada, the NAS incidence rate from January 2016 to September 2022 was 7.4 per 1,000 births. In 2022 alone, the rate of NAS was 8.9 per 1,000 births. Estimated rates of NAS were highest among neonates who were White at 13 per 1,000 births. Hospital J, the largest academic medical center in Southern Nevada, had the highest NAS confirmed case rate at 11.3 per 1000 newborn hospitalizations. Results from the multiple logistic regression model showed the odds of being born with NAS among neonates who identified as White were 5.0 (OR=5.17; 95% CI= 4.29 to 6.24; p <0.001) times more likely to have NAS compared to the Hispanic group.
Conclusion: Given that 2022 had the highest rate of confirmed NAS cases there is a need to collect substance and diagnosis-specific data about prenatal substance use to identify unmet service care and disparities.
Keywords:
neonatal abstinence syndrome, opioids, substance dependenceReferences
Anbalagan S, Mendez MD (2023). Neonatal abstinence syndrome. StatPearls Publishing LLC. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK551498/
Astho (2021). Strengthening health agencies’ neonatal abstinence syndrome surveillance through consensus-driven data standards and practices. Retrieved from https://www.astho.org/globalassets/pdf/strengthening-health-agencies-nas-surveillance-through-consensus-driven-data-standards-practices.pdf
Batra K, Cruz P, Cross CL, Bhandari N, Abdulla F, Pharr JR, Buttner MP (2021). Incidence of neonatal abstinence syndrome epidemic and associated predictors in Nevada: A State-wide Audit, 2016–2018. Int. J. Environ. Res. Public Health, 18(1), 1–11. doi: 10.3390/IJERPH18010232
Bauer E, Ahrens K, Carwile J (2021). Trends in diagnoses of neonatal abstinence syndrome at newborn hospitalization in Maine, 2009-2018. Journal of Maine Medical Center, 3(1), 4. doi: 10.46804/26412225.1071
CHIA (2022). Center for health information analysis for Nevada. Retrieved from https://chiaunlv.com/
CSTE (2019). Neonatal abstinence syndrome standardized case definition. Retrieved from https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/2019ps/19-MCH-01_NAS_updated_5.7.19.pdf
Czeisler MÉ, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, Weaver MD, et al. (2022). Mental health, substance use, and suicidal ideation during the COVID-19 Pandemic — United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 69(32), 1049–1057. doi: 10.15585/MMWR.MM6932A1
Healthcare Cost and Utilization Project (2022). HCUP fast stats, neonatal abstinence syndrome (NAS) among newborn hospitalizations. Retrieved from https://datatools.ahrq.gov/hc-up-fast-stats
Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW (2021). Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017. JAMA, 325(2), 146–155. doi: 10.1001/JAMA.2020.24991
Jilani SM, West K, Jacobus-Kantor L, Ali MM, Nyakeriga A, Lake-Burger H, Robinson M, et al. (2022). Evaluation of stateled surveillance of neonatal abstinence syndrome — Six U.S. States, 2018–2021. MMWR Morb Mortal Wkly Rep. 71(2), 37. doi: 10.15585/MMWR.MM7102A1
Leyenaar JK, Schaefer AP, Wasserman JR, Moen EL, O’Malley AJ, Goodman DC (2021). Infant mortality associated with prenatal opioid exposure. JAMA Pediatrics, 175(7), 1. doi: 10.1001/JAMAPEDIATRICS.2020.6364
Sisolak S, Whitley R (2019). Opioid prescription pattern pre- and post-implementation of AB474 excluding medication assisted treatment drugs. Retrieved from https://dpbh.nv.gov/uploadedFiles/dpbhnvgov/content/Resources/opioids/DHHS-data/PDMP-pre-post-AB474-2017-2019-MAT.pdf
Southern Nevada Health District (2022, August 15). Southern Nevada harm reduction alliance hosts its 6th international overdose awareness day event, august 31 – Southern Nevada Health District. Retrieved from https://www.southernnevadahealthdistrict.org/news-release/southern-nevada-harm-reduction-alliance-hosts-its-6th-international-overdose-awareness-day-event-august-31/
State of Nevada Department of Health and Human Services (2022). Nevada opioid needs assessment and statewide plan 2022 state of Nevada Department of Health and Human Services. Retrieved from https://www.nvnaco.org/wp-content/uploads/Nevada-Opioid-Needs-Assessment-and-Recovery-Plan.pdf
Strahan AE, Guy GP, Bohm M, Frey M, Ko JY (2020). Neonatal abstinence syndrome incidence and health care costs in the United States, 2016. JAMA Pediatrics, 174(2):200–202. doi: 10.1001/JAMAPEDIATRICS.2019.4791
U.S. Census Bureau (2022). U.S. Census Bureau QuickFacts: Clark County, Nevada. Retrieved from https://www.census.gov/quickfacts/clarkcountynevada
USDA (2022). USDA ERS - Rural-Urban Commuting Area Codes. Retrieved from https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes.aspx
Volkow ND, Blanco C (2021). The Changing Opioid Crisis: development, challenges and opportunities. Molecular Psychiatry, 26(1): 218. doi: 10.1038/S4138002006614
Weller AE, Crist RC, Reiner BC, Doyle GA, Berrettini WH (2021). Neonatal opioid withdrawal syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis. Cold Spring Harbor Perspectives in Medicine, 11(3), 1–12. doi: 10.1101/CSHPERSPECT.A039669